Reference | 1: Cornall LM, Hryciw DH, Mathai ML, McAinch AJ. Direct activation of the proposed anti-diabetic receptor, GPR119 in cardiomyoblasts decreases markers of muscle metabolic activity. Mol Cell Endocrinol. 2015 Feb 15;402:72-85. doi: 10.1016/j.mce.2015.01.006. Epub 2015 Jan 8. PubMed PMID: 25578601.<br />
2: Panaro BL, Tough IR, Engelstoft MS, Matthews RT, Digby GJ, Møller CL, Svendsen B, Gribble F, Reimann F, Holst JJ, Holst B, Schwartz TW, Cox HM, Cone RD. The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo. Cell Metab. 2014 Dec 2;20(6):1018-29. doi: 10.1016/j.cmet.2014.10.004. Epub 2014 Nov 20. PubMed PMID: 25453189; PubMed Central PMCID: PMC4255280.<br />
3: Ansarullah, Lu Y, Holstein M, DeRuyter B, Rabinovitch A, Guo Z. Stimulating β-cell regeneration by combining a GPR119 agonist with a DPP-IV inhibitor. PLoS One. 2013;8(1):e53345. doi: 10.1371/journal.pone.0053345. Epub 2013 Jan 29. PubMed PMID: 23382843; PubMed Central PMCID: PMC3558424.<br />
4: Cornall LM, Mathai ML, Hryciw DH, Simcocks AC, O/’Brien PE, Wentworth JM, McAinch AJ. GPR119 regulates genetic markers of fatty acid oxidation in cultured skeletal muscle myotubes. Mol Cell Endocrinol. 2013 Jan 5;365(1):108-18. doi: 10.1016/j.mce.2012.10.003. Epub 2012 Oct 13. PubMed PMID: 23069642.<br />
5: Gao J, Tian L, Weng G, Bhagroo NV, Sorenson RL, O/’Brien TD, Luo J, Guo Z. Stimulating beta cell replication and improving islet graft function by GPR119 agonists. Transpl Int. 2011 Nov;24(11):1124-34. doi: 10.1111/j.1432-2277.2011.01332.x. Epub 2011 Sep 8. PubMed PMID: 21902730.
|